news

news

US Grants Approval for Drug to Treat Rare Heart Condition

Attruby, transthyretin amyloid cardiomyopathy, BridgeBio, Pfizer, FDA approval

The oral medication Attruby has been approved by the U.S. FDA to treat adults with transthyretin amyloid cardiomyopathy (ATTR-CM), a condition where faulty transthyretin proteins accumulate in the heart, leading to potential organ failure. BridgeBio, the drug’s manufacturer, has set…